Caris Life Sciences, Inc. (CAI)
32.84
+0.74
(+2.31%)
USD |
NASDAQ |
Nov 03, 16:00
32.89
+0.05
(+0.15%)
After-Hours: 19:38
Caris Life Sciences Price to Book Value : 15.68 for Nov. 3, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 02, 2026 | 15.33 |
| October 30, 2026 | 16.39 |
| October 29, 2026 | 17.26 |
| October 28, 2026 | 16.93 |
| October 27, 2026 | 16.08 |
| October 26, 2026 | 15.50 |
| October 23, 2026 | 15.28 |
| October 22, 2026 | 15.14 |
| October 21, 2026 | 15.45 |
| October 20, 2026 | 14.86 |
| October 19, 2026 | 14.67 |
| October 16, 2026 | 14.59 |
| October 15, 2026 | 15.17 |
| October 14, 2026 | 14.45 |
| October 13, 2026 | 14.10 |
| October 12, 2026 | 14.18 |
| October 09, 2026 | 14.18 |
| October 08, 2026 | 13.13 |
| October 07, 2026 | 12.94 |
| October 06, 2026 | 13.11 |
| October 05, 2026 | 14.51 |
| October 02, 2026 | 13.51 |
| October 01, 2026 | 13.54 |
| September 30, 2026 | 14.63 |
| September 29, 2026 | 15.07 |
| Date | Value |
|---|---|
| September 28, 2026 | 15.16 |
| September 25, 2026 | 15.27 |
| September 24, 2026 | 15.41 |
| September 23, 2026 | 15.11 |
| September 22, 2026 | 15.03 |
| September 21, 2026 | 14.64 |
| September 18, 2026 | 14.32 |
| September 17, 2026 | 14.77 |
| September 16, 2026 | 13.47 |
| September 15, 2026 | 13.61 |
| September 14, 2026 | 12.44 |
| September 11, 2026 | 11.62 |
| September 10, 2026 | 11.48 |
| September 09, 2026 | 11.48 |
| September 08, 2026 | 11.85 |
| September 04, 2026 | 11.97 |
| September 03, 2026 | 12.09 |
| September 02, 2026 | 11.84 |
| September 01, 2026 | 11.83 |
| August 31, 2026 | 12.17 |
| August 28, 2026 | 12.24 |
| August 27, 2026 | 12.60 |
| August 26, 2026 | 12.81 |
| August 25, 2026 | 13.38 |
| August 24, 2026 | 12.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Natera, Inc. | 30.63 |
| Myriad Genetics, Inc. | 1.900 |
| BioRestorative Therapies, Inc. | 0.6357 |
| CareDx, Inc. | 9.930 |
| Exagen, Inc. | 16.50 |
Price to Book Value Related Metrics
| PE Ratio | 88.21 |
| PS Ratio | 9.375 |
| Price to Free Cash Flow | 79.81 |
| Price | 32.84 |
| Earnings Yield | 1.13% |
| Market Cap | 9.280B |
| Operating PE Ratio | 60.54 |
| Normalized PE Ratio | 73.85 |